TheraRadar
Clinical-Stage Companies / Citryll

Citryll

Pre-Approval PRO BETA
4
Total Trials
0
Phase 3
3
Phase 2
3
Recruiting
47
Score

Pipeline by Phase

Phase 3
Phase 2
3
Phase 1
1

Therapeutic Focus

Healthy Adult Rheumatoid Arthritis Hidradenitis Suppurativa (HS) RA

Clinical Trials (4)

NCT06567470 Phase 2 RECRUITING

A Study With CIT-013 in RA Patients

Started: 7/29/2025

NCT06993233 Phase 2 RECRUITING

A Study With CIT-013 in HS Patients

Started: 10/31/2025

NCT07147959 Phase 2 RECRUITING

PET-Based Imaging of Radiolabeled CIT-013

Started: 1/15/2026

NCT07499908 Phase 1 NOT YET RECRUITING

Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013

Started: 5/31/2026

Drug Candidates

CIT-013 high dose CIT-013 low dose CIT-013 medium dose [89Zr]Zr-CIT
Activity Status: Active
Last Trial Started: 5/31/2026
Last Trial Ended: N/A
Trials (12 months): 4
Completed Trials: 0
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.